Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4.

Casrouge A, Sauer AV, Barreira da Silva R, Tejera-Alhambra M, Sánchez-Ramón S, ICAReB, Cancrini C, Ingersoll MA, Aiuti A, Albert ML.

Clin Exp Immunol. 2018 Nov;194(2):166-179. doi: 10.1111/cei.13163. Epub 2018 Sep 24. Review.

2.

Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions.

Blauenfeldt T, Petrone L, Del Nonno F, Baiocchini A, Falasca L, Chiacchio T, Bondet V, Vanini V, Palmieri F, Galluccio G, Casrouge A, Eugen-Olsen J, Albert ML, Goletti D, Duffy D, Ruhwald M.

Front Immunol. 2018 Jul 5;9:1456. doi: 10.3389/fimmu.2018.01456. eCollection 2018.

3.

Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.

Ploquin MJ, Casrouge A, Madec Y, Noël N, Jacquelin B, Huot N, Duffy D, Jochems SP, Micci L, Lécuroux C, Boufassa F, Booiman T, Garcia-Tellez T, Ghislain M, Grand RL, Lambotte O, Kootstra N, Meyer L, Goujard C, Paiardini M, Albert ML, Müller-Trutwin M.

J Int AIDS Soc. 2018 Jul;21(7):e25144. doi: 10.1002/jia2.25144.

4.

Multimarker risk stratification approach at multiple sclerosis onset.

Fernández-Paredes L, Casrouge A, Decalf J, de Andrés C, Villar LM, Pérez de Diego R, Alonso B, Álvarez Cermeño JC, Arroyo R, Tejera-Alhambra M, Navarro J, Oreja-Guevara C, López Trascasa M, Seyfferth A, García Martínez MA, Álvarez Lafuente R, Albert ML, Sánchez-Ramón S.

Clin Immunol. 2017 Aug;181:43-50. doi: 10.1016/j.clim.2017.05.019. Epub 2017 May 31.

PMID:
28578025
5.

Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation.

Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, Serafini N, Puel A, Bustamante J, Surace L, Masse-Ranson G, David E, Strick-Marchand H, Le Bourhis L, Cocchi R, Topazio D, Graziano P, Muscarella LA, Rogge L, Norel X, Sallenave JM, Allez M, Graf T, Hendriks RW, Casanova JL, Amit I, Yssel H, Di Santo JP.

Cell. 2017 Mar 9;168(6):1086-1100.e10. doi: 10.1016/j.cell.2017.02.021.

6.

Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset.

Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, Lécuroux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, Petitjean G, Angin M, Gärtner K, Garcia-Tellez T, Noël N, Booiman T, Boeser-Nunnink BD, Roques P, Saez-Cirion A, Vaslin B, Dereudre-Bosquet N, Barré-Sinoussi F, Ghislain M, Rouzioux C, Lambotte O, Albert ML, Goujard C, Kootstra N, Meyer L, Müller-Trutwin MC.

PLoS Pathog. 2016 Aug 10;12(8):e1005774. doi: 10.1371/journal.ppat.1005774. eCollection 2016 Aug.

7.

Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies.

Decalf J, Tarbell KV, Casrouge A, Price JD, Linder G, Mottez E, Sultanik P, Mallet V, Pol S, Duffy D, Albert ML.

EMBO Mol Med. 2016 Jun 1;8(6):679-83. doi: 10.15252/emmm.201506145. Print 2016 Jun.

8.

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.

Meissner EG, Decalf J, Casrouge A, Masur H, Kottilil S, Albert ML, Duffy D.

PLoS One. 2015 Jul 16;10(7):e0133236. doi: 10.1371/journal.pone.0133236. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139818.

9.

Plasma biomarkers discriminate clinical forms of multiple sclerosis.

Tejera-Alhambra M, Casrouge A, de Andrés C, Seyfferth A, Ramos-Medina R, Alonso B, Vega J, Fernández-Paredes L, Albert ML, Sánchez-Ramón S.

PLoS One. 2015 Jun 3;10(6):e0128952. doi: 10.1371/journal.pone.0128952. eCollection 2015.

10.

Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.

Sultanik P, Mallet V, Lagaye S, Casrouge A, Dorival C, Barthe Y, Fontaine H, Hézode C, Mottez E, Bronowicki JP, Carrat F, Theodorou I, Abel L, Gayat E, Fontanet A, Pol S, Albert ML; ANRS CO20-CUPIC.

Liver Int. 2015 Jul;35(7):1833-44. doi: 10.1111/liv.12759. Epub 2015 Jan 23.

PMID:
25556540
11.

Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection.

Sultanik PS, Casrouge A, Alanio C, Mottez E, Rosa-Hézode I, Hézode C, Renard P, Bousquet L, Pellet P, Uzé G, Pol S, Albert ML, Mallet V.

J Viral Hepat. 2015 Jun;22(6):524-34. doi: 10.1111/jvh.12355. Epub 2014 Nov 10.

PMID:
25382001
12.

Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.

Laird ME, Mohsen A, Duffy D, Mamdouh R, LeFouler L, Casrouge A, El-Daly M, Rafik M, Abdel-Hamid M, Soulier A, Pawlotsky JM, Hézode C, Rosa I, Renard P, Mohamed MK, Bonnard P, Izopet J, Mallet V, Pol S, Albert ML, Fontanet A.

J Hepatol. 2014 Oct;61(4):770-6. doi: 10.1016/j.jhep.2014.05.040. Epub 2014 Jun 4.

PMID:
24905490
13.

Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection.

Riva A, Laird M, Casrouge A, Ambrozaitis A, Williams R, Naoumov NV, Albert ML, Chokshi S.

Hepatology. 2014 Aug;60(2):487-96. doi: 10.1002/hep.27139. Epub 2014 May 19.

PMID:
24668726
14.

The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis.

Duffy D, Mamdouh R, Laird M, Soneson C, Le Fouler L, El-Daly M, Casrouge A, Decalf J, Abbas A, Eldin NS, Fontes M, Abdel-Hamid M, Mohamed MK, Rafik M, Fontanet A, Albert ML.

Hepatology. 2014 Apr;59(4):1273-82. doi: 10.1002/hep.26901. Epub 2014 Feb 18.

PMID:
24500966
15.

Low DPP4 expression and activity in multiple sclerosis.

Tejera-Alhambra M, Casrouge A, de Andrés C, Ramos-Medina R, Alonso B, Vega J, Albert ML, Sánchez-Ramón S.

Clin Immunol. 2014 Feb;150(2):170-83. doi: 10.1016/j.clim.2013.11.011. Epub 2013 Nov 28.

PMID:
24412911
16.

CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients.

Ragab D, Laird M, Duffy D, Casrouge A, Mamdouh R, Abass A, Shenawy DE, Shebl AM, Elkashef WF, Zalata KR, Kamal M, Esmat G, Bonnard P, Fontanet A, Rafik M, Albert ML.

Cytokine. 2013 Aug;63(2):105-12. doi: 10.1016/j.cyto.2013.04.016. Epub 2013 May 7. Erratum in: Cytokine. 2014 Jan;65(1):119-20.

PMID:
23664274
17.

Discrimination of agonist and antagonist forms of CXCL10 in biological samples.

Casrouge A, Bisiaux A, Stephen L, Schmolz M, Mapes J, Pfister C, Pol S, Mallet V, Albert ML.

Clin Exp Immunol. 2012 Jan;167(1):137-48. doi: 10.1111/j.1365-2249.2011.04488.x.

18.

Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotype.

Albert ML, Casrouge A, Chevaliez S, Hézode C, Rosa I, Renard P, Mallet V, Fontanet A, Pawlotsky JM, Pol S.

Hepatology. 2011 Apr;53(4):1410-1. doi: 10.1002/hep.24055. No abstract available.

PMID:
21480356
19.

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML.

J Clin Invest. 2011 Jan;121(1):308-17. doi: 10.1172/JCI40594. Epub 2010 Dec 22.

20.

Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype.

Mansour H, Laird ME, Saleh R, Casrouge A, Eldin NS, El Kafrawy S, Hamdy M, Decalf J, Rosenberg BR, Fontanet A, Abdel-Hamid M, Mohamed MK, Albert ML, Rafik M.

J Infect Dis. 2010 Dec 1;202(11):1671-5. doi: 10.1086/656777. Epub 2010 Oct 19.

21.

TLR3 deficiency in patients with herpes simplex encephalitis.

Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL.

Science. 2007 Sep 14;317(5844):1522-7.

22.

Herpes simplex virus encephalitis in human UNC-93B deficiency.

Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Sénéchal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Héron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova JL.

Science. 2006 Oct 13;314(5797):308-12. Epub 2006 Sep 14.

23.

Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.

Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, Casrouge A, Yang K, Soudais C, Fieschi C, Santos OF, Bustamante J, Picard C, de Beaucoudrey L, Emile JF, Arkwright PD, Schreiber RD, Rolinck-Werninghaus C, Rösen-Wolff A, Magdorf K, Roesler J, Casanova JL.

PLoS Genet. 2006 Aug 18;2(8):e131.

24.

Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses.

Yang K, Puel A, Zhang S, Eidenschenk C, Ku CL, Casrouge A, Picard C, von Bernuth H, Senechal B, Plancoulaine S, Al-Hajjar S, Al-Ghonaium A, Maródi L, Davidson D, Speert D, Roifman C, Garty BZ, Ozinsky A, Barrat FJ, Coffman RL, Miller RL, Li X, Lebon P, Rodriguez-Gallego C, Chapel H, Geissmann F, Jouanguy E, Casanova JL.

Immunity. 2005 Nov;23(5):465-78.

25.

The human and mouse orthologous LIM-only proteins respectively encoded in chromosome 6 and 17 show a different expression pattern.

Casrouge A, Veitia R, Kirchner J, Bevan MJ, Kanellopoulos J.

Microbes Infect. 2004 Oct;6(12):1063-72.

26.

[Methods of studying T-lymphocyte repertoires].

Casrouge A, Fazilleau N, Cabaniols JP, Kourilsky P, Kanellopoulos JM.

Pathol Biol (Paris). 2002 Apr;50(3):151-6. French. No abstract available.

PMID:
11980327
27.

Most alpha/beta T cell receptor diversity is due to terminal deoxynucleotidyl transferase.

Cabaniols JP, Fazilleau N, Casrouge A, Kourilsky P, Kanellopoulos JM.

J Exp Med. 2001 Nov 5;194(9):1385-90.

28.

V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules.

Laouini D, Casrouge A, Dalle S, Lemonnier F, Kourilsky P, Kanellopoulos J.

J Immunol. 2000 Dec 1;165(11):6381-6.

29.

Diversity of human alpha beta T cell receptors.

Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P.

Science. 2000 May 19;288(5469):1135. No abstract available.

30.

Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes.

Casrouge A, Beaudoing E, Dalle S, Pannetier C, Kanellopoulos J, Kourilsky P.

J Immunol. 2000 Jun 1;164(11):5782-7.

31.

A direct estimate of the human alphabeta T cell receptor diversity.

Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P.

Science. 1999 Oct 29;286(5441):958-61.

32.

Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires.

Bousso P, Casrouge A, Altman JD, Haury M, Kanellopoulos J, Abastado JP, Kourilsky P.

Immunity. 1998 Aug;9(2):169-78.

33.

Quantitative analysis of the T cell repertoire selected by a single peptide-major histocompatibility complex.

Gapin L, Fukui Y, Kanellopoulos J, Sano T, Casrouge A, Malier V, Beaudoing E, Gautheret D, Claverie JM, Sasazuki T, Kourilsky P.

J Exp Med. 1998 Jun 1;187(11):1871-83.

34.

Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.

Gapin L, Bravo de Alba Y, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J.

J Immunol. 1998 Feb 15;160(4):1555-64.

35.
36.

Use of synthetic peptide libraries for the H-2Kd binding motif identification.

Quesnel A, Casrouge A, Kourilsky P, Abastado JP, Trudelle Y.

Pept Res. 1995 Jan-Feb;8(1):44-51.

PMID:
7756754
37.

Dissociation of the peptide-MHC class I complex limits the binding rate of exogenous peptide.

Ojcius DM, Abastado JP, Casrouge A, Mottez E, Cabanie L, Kourilsky P.

J Immunol. 1993 Dec 1;151(11):6020-6.

PMID:
8245447
38.
39.

A soluble, single-chain Kd molecule produced by yeast selects a peptide repertoire indistinguishable from that of cell-surface-associated Kd.

Abastado JP, Ojcius DM, Casrouge A, Yeh P, Schumacher TN, Ploegh HL, Kourilsky P.

Eur J Immunol. 1993 Aug;23(8):1776-83.

PMID:
8344339
40.

The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments.

Pannetier C, Cochet M, Darche S, Casrouge A, Zöller M, Kourilsky P.

Proc Natl Acad Sci U S A. 1993 May 1;90(9):4319-23.

41.

Co-expression of T-cell receptor beta and delta mRNA detected at high frequency in hybridomas derived from adult thymus.

Spetz AL, Casrouge A, Cochet M, Kourilsky P, Larsson-Sciard EL.

Scand J Immunol. 1992 Aug;36(2):167-75.

PMID:
1386937
43.

A new cell surface molecule closely related to mouse class I transplantation antigens.

Cochet M, Casrouge A, Dumont AM, Transy C, Baleux F, Maloy WL, Coligan JE, Cazenave PA, Kourilsky P.

Eur J Immunol. 1989 Oct;19(10):1927-31.

PMID:
2583228

Supplemental Content

Loading ...
Support Center